NASH

Targeting the complexities of NASH

There are currently no approved treatments for nonalcoholic fatty liver disease (NAFLD) or nonalcoholic steatohepatitis (NASH) and diagnosis remains challenging. But studies show that fat and scar tissue can leave the liver, suggesting that NAFLD and NASH are reversible.

That's where we can help - Revvity offers a comprehensive portfolio of tools to enable further understanding of NASH pathophysiology, aid in the development of NASH diagnostic solutions for the assessment of NASH, help identify new therapeutic targets, and characterize novel drug therapies.

For research use only. Not for use in diagnostic procedures.

Explore our solutions

Microplate Readers

As many of you know, microplate readers are instruments used to detect biological, chemical, biochemical or physical events from samples in a microplate.

Learn more

Cellular Imaging & Analysis

Answer complex cell biology questions with powerful cellular imaging and analysis solutions, including systems, reagents, microplates, software and automation.

Learn more

In Vivo Imaging

Track, monitor, and visualize biological processes and disease progression with our industry-leading in vivo imaging systems and reagents.

Learn more

Microplates

Choosing the right microplate is a critical, often overlooked, part of an assay. The right microplate helps provides valuable data, whereas the wrong microplate can lead to missed or inaccurate data leading to missed project timelines and ultimately higher costs.

Learn more

Platforms & Automation

At Revvity, we are increasing access to healthcare technology with a full range of scalable platforms to serve all laboratories.

Learn more

Radiometric Detectors

Radiometric detection has long been and remains today as the gold standard used by researchers in many scientific applications such as analyzing drug pathways, protecting lab environments, assessing environmental contamination, and monitoring food safety.

Learn more